Evidence map›Paper›PMID 38183377›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2024

Genetic risk score for Alzheimer's disease predicts brain volume differences in mid and late life in UK biobank participants.

Peter T Buto, Jingxuan Wang, Renaud La Joie, Scott C Zimmerman, M Maria Glymour, Sarah F Ackley, Thomas J Hoffmann, Kristine Yaffe, Adina Zeki Al Hazzouri, Willa D Brenowitz

Open access · hybridAbstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Neural embedding of frailty in cognitively unimpaired aging and dementia across Latin America.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Peter T ButoDepartment of Epidemiology & Biostatistics, University of California, San Francisco, California, USA.
Jingxuan WangDepartment of Epidemiology & Biostatistics, University of California, San Francisco, California, USA.
Renaud La JoieMemory and Aging Center, University of California, San Francisco, California, USA.
Scott C ZimmermanDepartment of Epidemiology & Biostatistics, University of California, San Francisco, California, USA.
M Maria GlymourDepartment of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, USA.
Sarah F AckleyDepartment of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, USA.
Thomas J HoffmannDepartment of Epidemiology & Biostatistics, University of California, San Francisco, California, USA.
Kristine YaffeDepartment of Epidemiology & Biostatistics, University of California, San Francisco, California, USA.
Adina Zeki Al HazzouriDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.
Willa D BrenowitzDepartment of Epidemiology & Biostatistics, University of California, San Francisco, California, USA.
University of California, San Francisco · USBoston University · USColumbia University · USKaiser Permanente Center for Health Research · USUniversity Memory and Aging Center · US

Funding

Building an unbiased pooled cohort for the study of lifecourse social and vascular determinants of Alzheimer's Disease and Related DisordersR01AG072681 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GLYMOUR, MEDELLENA MARIA, ZEKI AL HAZZOURI, ADINA · 2021 to 2025
$4.0M
Population Based Research for Alzheimer's Innovation (POP BRAIN)R35AG071916 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI YAFFE, KRISTINE · 2021 to 2024
$3.8M
Sensory Impairments, Cognitive Decline, and Dementia: What Explains the Association?K01AG062722 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BRENOWITZ, WILLA DOMINO · 2019 to 2023
$652k
Mathematical Models of Tau-PET Measures and Cognitive Decline in Alzheimer’s Disease Across the LifespanK99AG073454 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ACKLEY, SARAH · 2022 to 2024
$250k
The Impact of SARS-CoV-2 Infection and Vaccination on the Risk of Alzheimer’s Disease and Related DementiasF99AG083306 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WANG, JINGXUAN · 2023 to 2025
$72k
NIA NIH HHS F99 AG083306NIA NIH HHS K01 AG062722NIA NIH HHS K99 AG073454NIA NIH HHS R01 AG072681NIA NIH HHS R35 AG071916Wellcome Trust
6 · The paper itself

Abstract

introductionWe estimated the ages when associations between Alzheimer's disease (AD) genes and brain volumes begin among middle-aged and older adults.

methodsAmong 45,616 dementia-free participants aged 45-80, linear regressions tested whether genetic risk score for AD (AD-GRS) had age-dependent associations with 38 regional brain magnetic resonance imaging volumes. Models were adjusted for sex, assessment center, genetic ancestry, and intracranial volume.

resultsAD-GRS modified the estimated effect of age (per decade) on the amygdala (-0.41 mm DISCUSSION: APOE and other genes that increase AD risk predict lower hippocampal and other brain volumes by middle age.

Indexed as

Alzheimer DiseaseAgedApolipoproteins EBiological Specimen BanksBrainGenetic Risk ScoreHippocampusHumansMagnetic Resonance ImagingMiddle AgedUK BiobankApolipoproteins EageAlzheimer's diseasedementiagenetic risk scoremagnetic resonance imaging (MRI)neurodegeneration

Identifiers

PMID38183377
PMCPMC10984491
OpenAlexW4390636851

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.